Revvity and Element Biosciences Collaboration | To Advance Sequencing-based IVD Neonatal Testing
“This strategic endeavor represents a significant step forward in our [...]
Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
“The submission of the BLA marks a pivotal step for [...]
PharmaEssentia Reaffirms its Commitment to Robust and Reliable Access to Interferon Therapies Amid Global Supply Challenges
“Our longstanding commitment to operational resilience has positioned us to [...]
YolTech Therapeutics Granted FDA Orphan Drug and Rare Pediatric Disease Designations for YOLT-203 to Treat Primary Hyperoxaluria Type 1
After reviewing YolTech Therapeutics submission, the FDA determined that the [...]
Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the “AD-DMT Registry” in Japan
Eisai and Biogen Japan will continue to contribute to the [...]
Intensity Therapeutics Presents INT230-6 Phase 1/2 Data in Sarcoma and an Overview of its Ongoing Global Randomized Phase 3 Sarcoma Trial (“INVINCIBLE-3 Study”) in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society Meeting (CTOS)
Phase 1/2 data showed a median overall survival (“mOS”) of [...]
Immorta Bio Reports | SenoVax™ Reduces Growth and Stops Metastasis of Aggressive Breast Cancer Using its First-In-Class Immune Stimulatory Therapy
SenoVax has previously been demonstrated to reduce lung cancer growth1, [...]
BioHub Maryland Opens New Biopharma Workforce Training Center in Montgomery County’s Life Sciences Corridor
BioHub Maryland is a skills-first workforce development initiative of the [...]
TMRW Life Sciences and Cryoport Systems Form Strategic Partnership
“This partnership with Cryoport reflects our dedication to providing patients [...]
Revolo Biotherapeutics Shares New Preclinical Data Showcasing the Potential of Sublingual ‘1104 in Allergic Disease
Revolo Biotherapeutics notes additionally, the data continues to demonstrate the [...]